Basic Information

Gene symbol S Synonyms E2 Type of gene protein-coding
Gene perturbation-related omics dataset PerturbAtlas
Description spike glycoprotein

GTO ID GTC2779
Trial ID NCT05030974
Disease COVID-19
Altered gene S
Therapeutic/Target gene Therapeutic gene
TherapymRNA vaccine
Treatment mRNA-1273|Elasomeran|Spikevax
Location approved UK, Canada, Taiwan, Switzerland, Japan, EU, Australia, South Korea, Singapore, US
PhasePhase4
Recruitment statusCompleted
TitleOptimal Repeated Dose Strategy for SARS-CoV-2 Vaccination in Kidney Transplant Patients A Prospective, Randomized Multicenter Study by the REnal Patients COVID-19 VACcination (RECOVAC) Consortium
Year2021
CountryNetherlands
Company sponsorNYU Langone Health
Other ID(s)NL78963.042.21
Vector information
Vectoradenovirus|lipid nanoparticle

Clinical Result

Cohort1: MMF/MPA_3rd or 4th dose_mRNA-1273
Administration route intramuscular injection
Dosage mRNA-1273, 100 μg
Pts 46
Age Adult, Older_Adult
References PMID: 36354032
Cohort2: 3rd or 4th dose_mRNA-1273
Administration route intramuscular injection
Dosage mRNA-1273, 100 μg
Pts 46
Age Adult, Older_Adult
References PMID: 36354032
Cohort3: 3rd dose_mRNA-1273
Administration route intramuscular injection
Dosage mRNA-1273, 100 μg
Pts 73
Age Adult, Older_Adult
References PMID: 36354032
Cohort4: 3rd double dose_mRNA-1273
Administration route intramuscular injection
Dosage mRNA-1273, 100 μg
Pts 72
Age Adult, Older_Adult
References PMID: 36354032
Cohort5: Ad26.COV2.S
Administration route intramuscular injection
Dosage Ad26.COV2.S, 5x1010 viral particles
Pts 73
Age Adult, Older_Adult
References PMID: 36354032

Relationship Graph

Overview of Knowledge Graph